Astrazeneca Pharma India Dividend Details
Record Date
18-Jul-2025
Dividends Date
18-Jul-2025
Ex Date
18-Jul-2025
Dividend Type
Equity Share
Dividend Per Share
₹32.00
The Astrazeneca Pharma India has declared a Equity Share dividend of ₹32.00 per share. Investors should note the Astrazeneca Pharma India dividend 2026 record date is 18-Jul-2025, and the Astrazeneca Pharma India ex-dividend date is 18-Jul-2025 to confirm eligibility for the payout. This move underscores the Astrazeneca Pharma India ongoing efforts to enhance shareholder value through regular dividend distributions.
Astrazeneca Pharma India Dividend History
| Record Date | Dividend Per Share | Dividend Type | Ex-Date |
|---|---|---|---|
| 18-Jul-2025 | ₹32.00 | Equity Share | 18-Jul-2025 |
Upcoming Dividends by Indian Companies
View More| Company | Dividends Ratio | Announcement | Record Date | Dividends Date |
|---|---|---|---|---|
| Engineers India Ltd. | 0 | 17-Feb-2026 | 06-Mar-2026 | 06-Mar-2026 |
| SBI Life Insurance Company Ltd. | 0.27 | 23-Feb-2026 | 06-Mar-2026 | 06-Mar-2026 |
Astrazeneca Pharma India Dividend FAQs
The latest dividend declared by Astrazeneca Pharma India is of 16 per share for the financial year as announced on 18-Jul-2025.
Registered shareholders who own Astrazeneca Pharma India’s shares on or before the record date of 18-Jul-2025 set by the company are eligible to receive the dividend. You will not be entitled to the payout if you purchase shares on or after the ex-dividend date of 18-Jul-2025.
You can expect to receive Astrazeneca Pharma India’s dividend in your bank account linked to your Demat account within 25 to 45 business days after the record date of 18-Jul-2025. The record date is when Astrazeneca Pharma India identifies eligible shareholders for the dividend payment.
The annual dividend paid by Astrazeneca Pharma India varies according to its financial performance and dividend policy. Generally, companies in different sectors exhibit varying dividend yields. To determine Astrazeneca Pharma India's specific annual dividend, it’s advisable to consult the company's official investor relations website or recent financial statements.
Astrazeneca Pharma India Associated Pages
